Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Whitbourn

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|April 22, 2014
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trialsTakashi Muramatsu, Yoshinobu Onuma, Robert-Jan van Geuns, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
The International Journal of Cardiovascular Imaging|October 14, 2010
Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffoldSalvatore Brugaletta, Hector M Garcia-Garcia, Scot Garg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|April 22, 2014
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trialsTakashi Muramatsu, Yoshinobu Onuma, Robert-Jan van Geuns, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 23, 2013
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stentIan T Meredith, Stefan Verheye, Neil J Weissman, et al.
JACC. Cardiovascular Interventions|September 24, 2011
Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomographyJosep Gomez-Lara, Maria Radu, Salvatore Brugaletta, et al.
Circulation|November 25, 2010
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, John A Ormiston, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2014
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography dataChristos V Bourantas, Patrick W Serruys, Shimpei Nakatani, et al.
JACC. Cardiovascular Interventions|December 24, 2011
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomographyJosep Gomez-Lara, Salvatore Brugaletta, Vasim Farooq, et al.
Journal of the American College of Cardiology|October 1, 2011
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomesPatrick W Serruys, Yoshinobu Onuma, Dariusz Dudek, et al.
Circulation. Cardiovascular Interventions|September 13, 2017
Serial 5-Year Evaluation of Side Branches Jailed by Bioresorbable Vascular Scaffolds Using 3-Dimensional Optical Coherence Tomography: Insights From the ABSORB Cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)Yoshinobu Onuma, Maik J Grundeken, Shimpei Nakatani, et al.
Pageof 10